u/investorinvestor

Reddit r/ValueInvesting
· tracked since May 2026
Calls
2
Win Rate
50.0%
return
+9.0%
Calls 2 3 Posts tracked · 0.0/day
Calls
7d 0
30d 0
90d 2
Best Calls
PYPL Long +24.7%
Worst Calls
ZTS Long -6.7%
Most Mentioned
ZTS ×2
PYPL ×1
Recent Calls
ZTS Long 1 month ago
PYPL Long 2 months ago
Win Rate 50% Long 2 Short 0
Win Rate
7d 0%
30d 0%
90d
Average Return +9.0% Long Return +9.0% Short Return -
Average Return
7d -4.6%
30d -5.7%
90d
Loading charts...
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
May 26
$82.00
-6.7%
ZTS trades at 13x P/E while delivering 9% EPS growth, and management increased debt by 50% to fund buybacks. The combination of low valuation, positive EPS growth, and aggressive management buybacks (signaling intrinsic value > current price) creates a contrarian value opportunity. Buy ZTS as a value play on temporary pet sector headwinds, with management providing a strong signal through leveraged buybacks. Continued contraction in the pet segment; macro slowdown in animal health spending; rising debt service costs if rates stay high.
ZTS trades at 13x P/E while delivering 9% EPS growth, and management increased debt by 50% to fund buybacks. The combination of low valuation, positive EPS growth, and aggressive management buybacks (signaling intrinsic value > current price) creates a contrarian value opportunity. Buy ZTS as a value play on temporary pet sector headwinds, with management providing a strong signal through leveraged buybacks. Continued contraction in the pet segment; macro slowdown in animal health spending; rising debt service costs if rates stay high.
Pharma & Biotech
Long
May 14
$45.36
+24.7%
Management plans 12% annual share count reduction and drastic cost cuts; normalized EPS could grow 50%. If EPS grows and sentiment improves, PE could double from ~8x to 16x, creating a 3x price move; options now cheap. Long PYPL (stock or cheap calls) to capture potential turnaround re-rating. Turnaround fails, revenue declines, competition (e.g., Block, Apple Pay), macro headwinds, or buyback not executed.
Management plans 12% annual share count reduction and drastic cost cuts; normalized EPS could grow 50%. If EPS grows and sentiment improves, PE could double from ~8x to 16x, creating a 3x price move; options now cheap. Long PYPL (stock or cheap calls) to capture potential turnaround re-rating. Turnaround fails, revenue declines, competition (e.g., Block, Apple Pay), macro headwinds, or buyback not executed.
Payments & Fintech
Showing 2 of 2 calls · sorted by mentions

u/investorinvestor has 2 trade ideas tracked on Buzzberg across 2 tickers since May 2026. Most covered: ZTS, PYPL.